Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Single, Site, Pragmatic Pilot Study

Protocol No
RHEU-IIT-SINGLA-GLP-1
Phase
N/A
Summary

This project is being done to investigate the role of GLP-1 analogs in improving disease outcomes in a cohort of patients with moderate- high disease activity of Psoriatic Arthritis (PsA) that are currently needing treatment for obesity and type 2 diabetes.

Objective
Impact of Glucagon-like Peptide on Disease Outcomes
Status
OPEN TO ACCRUAL
Categories